The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Geographic differences in clinical characteristics and management of COPD: the EPOCA study
Open accessAbstract
AIMS: Data on differences in clinical characteristics and management of COPD in different countries and settings are limited. We aimed to characterize the profile of patients with COPD in a number of countries and their treatment in order to evaluate adherence to recommendations of international guidelines. METHOD: This was an observational, international, cross-sectional study on patients with physician-diagnosed COPD. Demographic and clinical characteristics, risk factors, and treatment were collected by their physician via an internet web-based questionnaire developed for the study. RESULTS: A total of 77 investigators from 17 countries provided data on 833 patients. The countries with the highest number of patients included were: Argentina (128), Ecuador (134), Spain (162), and Hong Kong (153). Overall, 79.3% were men and 81% former smokers, with a mean FEV1 = 42.7%, ranging from 34.3% in Hong Kong to 58.8% in Ecuador. Patients reported a mean of 1.6 exacerbations the previous year, with this frequency being significantly and negatively correlated with FEV1 (%) (r = -0.256; p < 0.0001). Treatment with short-acting bronchodilators and theophyllines was more frequent in Ecuador and Hong Kong compared with Spain and Argentina, and in patients belonging to lower socioeconomic levels (p < 0.0001 for all comparisons). Inadequacy of treatment with inhaled corticosteroids and theophyllines was high, with significant differences among countries. CONCLUSIONS: Differences in the clinical characteristics and management of COPD were significant across countries. Adherence to international guidelines appears to be low. Efforts should be made to disseminate and adapt guidelines to the socioeconomic reality of different settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The lack of data on COPD admission to hospital is a limiting factor, although published for several countries [116,117].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Standardization of Spirometry, 1994 Update. American Thoracic Society
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,605
PAUWELS, R. A., Buist, A. S., CALVERLEY, P. M. A., Jenkins, C. R., & Hurd, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,572
Standardization of Spirometry — 1987 Update
Buist, A. S. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.5.1073 · Cited by 3,256
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61377-4 · Cited by 2,364
Global burden of COPD: systematic review and meta-analysis
Halbert, R. J., Natoli, J. L., Gano, A. D., Badamgarav, E., Buist, A. S., & Mannino, D. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00124605 · Cited by 1,485
Trends in the leading causes of death in the United States, 1970-2002.
Jemal, A., Ward, E. M., Hao, Y.-P., & Thun, M. (2005) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.294.10.1255 · Cited by 1,054
Menezes, A. M. B., Pérez‐Padilla, R., Jardim, J. R., Muiño, A., López, M. V., Valdivia, G. G., de, M. M., Tálamo, C., Hallal, P. C., & Victora, C. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67632-5 · Cited by 1,012
Prevalence of Chronic Obstructive Pulmonary Disease in China
Zhong, N., Wang, C., Yao, W.-Z., Chen, P., Kang, J., Huang, S., Chen, B.-Y., Wang, C., Ni, D.-T., Zhou, Y., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200612-1749oc · Cited by 733
Cited by
Sorted by citations
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“The lack of data on COPD admission to hospital is a limiting factor, although published for several countries [116,117].”
BackgroundPrevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities
Miravitlles, M., Soriano, J. B., Rio, F. G., Muñoz, L., Duran‐Tauleria, E., Sánchez, G., Sobradillo, V., & Ancochea, J. (2009) · Thorax · doi:10.1136/thx.2009.115725 · Cited by 640
Self-citationCognitive impairment in COPD: a systematic review
Torres‐Sánchez, I., Alzueta, E., Martos, I. C., López-Torres, I., Moreno-Ramírez, M. P., & Valenza, M. C. (2015) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132015000004424 · Cited by 143
The global impact of Aspergillus infection on COPD
Hammond, E. E., McDonald, C. S., Vestbo, J., & Denning, D. W. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01259-8 · Cited by 111
Pathophysiology of dyspnea in COPD
Anzueto, A., & Miravitlles, M. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1301190 · Cited by 108
Self-citation
Metadata
- Authors
- Miravitlles, M.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Corresponding author
- Miravitlles, Marc
- ORCID
- Miravitlles, Marc
- Venue
- International Journal of Chronic Obstructive Pulmonary Disease
- Publisher
- Informa UK Limited
- Published
- 2008-12
- Volume
- Volume 3
- Issue
- 4
- Pages
- 803-814
- ISSN
- 1176-9106 (ISSN-L)
- 1178-2005
- PMC
- PMC2650616
- OpenAlex
- W2112674445
- Cited by
- 58
- References
- 42
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 3 · 2021: 4 · 2020: 6 · 2019: 3 · 2018: 4 · 2017: 7 · 2016: 1 · 2015: 4 · 2014: 2 · 2013: 5 · 2012: 1
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of COPD (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- GlaxoSmithKline
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- chronic obstructive pulmonary disease, regional variation, clinical features, COPD management, guideline adherence, exacerbations, FEV1, short-acting bronchodilators, theophylline, inhaled corticosteroids, socioeconomic status, cross-national comparison
- MeSH terms
- Administration, Inhalation, Adrenal Cortex Hormones, Aged, Aged, 80 and over, Bronchodilator Agents, Cross-Sectional Studies, Drug Utilization, Female, Forced Expiratory Volume, Humans, International Cooperation, Male, Middle Aged, Practice Patterns, Physicians', Prospective Studies, Surveys and Questionnaires, Residence Characteristics, Social Class, Theophylline, Treatment Outcome, Practice Guidelines as Topic, Respiratory System Agents, Health Care Surveys, Guideline Adherence, Internet, Pulmonary Disease, Chronic Obstructive, Health Status Disparities, Healthcare Disparities, Prescription Drugs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
